Table of Content

Table of Contents

Global Oncology Immunotherapy Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Oncology Immunotherapy Market by Value
2.2.1 Global Oncology Immunotherapy Revenue by Type
2.2.2 Global Oncology Immunotherapy Market by Value (%)
2.3 Global Oncology Immunotherapy Market by Production
2.3.1 Global Oncology Immunotherapy Production by Type
2.3.2 Global Oncology Immunotherapy Market by Production (%)

3. The Major Driver of Oncology Immunotherapy Industry
3.1 Historical & Forecast Global Oncology Immunotherapy Demand
3.2 Largest Application for Oncology Immunotherapy (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Oncology Immunotherapy Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Oncology Immunotherapy Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Oncology Immunotherapy Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Oncology Immunotherapy Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Oncology Immunotherapy Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Oncology Immunotherapy Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Oncology Immunotherapy Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Oncology Immunotherapy Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Oncology Immunotherapy Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Oncology Immunotherapy Average Price Trend
12.1 Market Price for Each Type of Oncology Immunotherapy in US (2018-2022)
12.2 Market Price for Each Type of Oncology Immunotherapy in Europe (2018-2022)
12.3 Market Price for Each Type of Oncology Immunotherapy in China (2018-2022)
12.4 Market Price for Each Type of Oncology Immunotherapy in Japan (2018-2022)
12.5 Market Price for Each Type of Oncology Immunotherapy in India (2018-2022)
12.6 Market Price for Each Type of Oncology Immunotherapy in Korea (2018-2022)
12.7 Market Price for Each Type of Oncology Immunotherapy in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Oncology Immunotherapy Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Oncology Immunotherapy

14. Oncology Immunotherapy Competitive Landscape
14.1 Bristol-Myers Squibb
14.1.1 Bristol-Myers Squibb Company Profiles
14.1.2 Bristol-Myers Squibb Product Introduction
14.1.3 Bristol-Myers Squibb Oncology Immunotherapy Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Merck & Co
14.2.1 Merck & Co Company Profiles
14.2.2 Merck & Co Product Introduction
14.2.3 Merck & Co Oncology Immunotherapy Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Roche AG
14.3.1 Roche AG Company Profiles
14.3.2 Roche AG Product Introduction
14.3.3 Roche AG Oncology Immunotherapy Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 AstraZeneca
14.4.1 AstraZeneca Company Profiles
14.4.2 AstraZeneca Product Introduction
14.4.3 AstraZeneca Oncology Immunotherapy Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Sanofi S.A.
14.5.1 Sanofi S.A. Company Profiles
14.5.2 Sanofi S.A. Product Introduction
14.5.3 Sanofi S.A. Oncology Immunotherapy Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Dendreon Pharmaceuticals
14.6.1 Dendreon Pharmaceuticals Company Profiles
14.6.2 Dendreon Pharmaceuticals Product Introduction
14.6.3 Dendreon Pharmaceuticals Oncology Immunotherapy Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Novartis
14.7.1 Novartis Company Profiles
14.7.2 Novartis Product Introduction
14.7.3 Novartis Oncology Immunotherapy Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Gilead Sciences Inc.
14.8.1 Gilead Sciences Inc. Company Profiles
14.8.2 Gilead Sciences Inc. Product Introduction
14.8.3 Gilead Sciences Inc. Oncology Immunotherapy Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Merck KGaA
14.9.1 Merck KGaA Company Profiles
14.9.2 Merck KGaA Product Introduction
14.9.3 Merck KGaA Oncology Immunotherapy Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
15. Conclusion
16. Methodology and Data Source

List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Oncology Immunotherapy Industry (Volume)
Figure 2. Oncology Immunotherapy Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Oncology Immunotherapy Revenue in 2022
Figure 5. US Oncology Immunotherapy Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Oncology Immunotherapy Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Oncology Immunotherapy Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Oncology Immunotherapy Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Oncology Immunotherapy Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Oncology Immunotherapy Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Oncology Immunotherapy Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Oncology Immunotherapy Revenue, by Type (Million USD) (2018-2028)
Table 4. Oncology Immunotherapy Production, by Type (K Unit) (2018-2028)
Table 5. Oncology Immunotherapy Demand (K Unit) by Application (2018-2028)
Table 6. Oncology Immunotherapy Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Oncology Immunotherapy Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Oncology Immunotherapy Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Oncology Immunotherapy Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Oncology Immunotherapy Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Oncology Immunotherapy Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Oncology Immunotherapy Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Oncology Immunotherapy Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Oncology Immunotherapy Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Oncology Immunotherapy in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Oncology Immunotherapy in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Oncology Immunotherapy in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Oncology Immunotherapy in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Oncology Immunotherapy in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Oncology Immunotherapy in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Oncology Immunotherapy in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Bristol-Myers Squibb Profiles
Table 61. Bristol-Myers Squibb Oncology Immunotherapy Product Introduction
Table 62. Bristol-Myers Squibb Oncology Immunotherapy Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Bristol-Myers Squibb Strategic initiatives
Table 64. Merck & Co Profiles
Table 65. Merck & Co Oncology Immunotherapy Product Introduction
Table 66. Merck & Co Oncology Immunotherapy Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Merck & Co Strategic initiatives
Table 68. Roche AG Profiles
Table 69. Roche AG Oncology Immunotherapy Product Introduction
Table 70. Roche AG Oncology Immunotherapy Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Roche AG Strategic initiatives
Table 72. AstraZeneca Profiles
Table 73. AstraZeneca Oncology Immunotherapy Product Introduction
Table 74. AstraZeneca Oncology Immunotherapy Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. AstraZeneca Strategic initiatives
Table 76. Sanofi S.A. Profiles
Table 77. Sanofi S.A. Oncology Immunotherapy Product Introduction
Table 78. Sanofi S.A. Oncology Immunotherapy Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Sanofi S.A. Strategic initiatives
Table 80. Dendreon Pharmaceuticals Profiles
Table 81. Dendreon Pharmaceuticals Oncology Immunotherapy Product Introduction
Table 82. Dendreon Pharmaceuticals Oncology Immunotherapy Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. Dendreon Pharmaceuticals Strategic initiatives
Table 84. Novartis Profiles
Table 85. Novartis Oncology Immunotherapy Product Introduction
Table 86. Novartis Oncology Immunotherapy Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. Novartis Strategic initiatives
Table 88. Gilead Sciences Inc. Profiles
Table 89. Gilead Sciences Inc. Oncology Immunotherapy Product Introduction
Table 90. Gilead Sciences Inc. Oncology Immunotherapy Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. Gilead Sciences Inc. Strategic initiatives
Table 92. Merck KGaA Profiles
Table 93. Merck KGaA Oncology Immunotherapy Product Introduction
Table 94. Merck KGaA Oncology Immunotherapy Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. Merck KGaA Strategic initiatives